Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease.

Cancer research in the U.S. doesn’t rely on a single institution or funding stream − it’s a complex ecosystem made up of interdependent parts: academia, pharmaceutical companies, biotechnology ...

Following the launch of two new cancer tests—plus a third planned for before the end of 2025—Exact Sciences is nudging up its ...

At the University of British Columbia, the Blakney Lab is focused on developing vaccines and therapies using self-amplifying ...

A team of researchers from the Keck School of Medicine of USC has developed an advanced tool for analyzing chimeric antigen ...

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

Chemical & Materials Engineering Assistant Professor Maryam Raeeszadeh-Sarmazdeh shares a few thoughts about her work and the ...

The American Association for Cancer Research’s annual conference continued Tuesday with Marengo Therapeutics making progress ...

MAIA Biotechnology, Inc.’s MAIA share price has dipped by 6.09%, which has investors questioning if this is right time to buy ...

ImmunityBio, Inc. faces stock decline amid fundraising and market selloff. Click to read more on the long-term potential of ...

The news sent the stock of South San Francisco' Vaxart Inc. (Nasdaq: VXRT) nearly 17% higher Monday morning, or 6.7 cents, to ...